Published in Biomol Ther (Seoul) on March 01, 2016
Natural Polyphenols for Prevention and Treatment of Cancer. Nutrients (2016) 0.79
Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology. PLoS One (2017) 0.75
The citrus flavonoid naringenin confers protection in a murine endotoxaemia model through AMPK-ATF3-dependent negative regulation of the TLR4 signalling pathway. Sci Rep (2016) 0.75
Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis. Onco Targets Ther (2017) 0.75
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Flavonoids as antioxidants. J Nat Prod (2000) 6.02
ATF3 and stress responses. Gene Expr (1999) 3.31
Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm Res (2009) 2.00
Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem (2006) 1.99
Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem (1997) 1.84
Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J (2005) 1.67
Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH(2)-terminal kinase and promoter response element. Blood (2000) 1.54
The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J (2007) 1.52
Chemopreventive effects of natural dietary compounds on cancer development. Chem Soc Rev (2008) 1.49
Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis (2004) 1.43
Indole-3-carbinol and 3,3'-diindolylmethane induce expression of NAG-1 in a p53-independent manner. Biochem Biophys Res Commun (2005) 1.42
Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis (2005) 1.40
Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway. Cancer Res (2006) 1.27
Dietary flavonoid and cancer prevention: evidence and potential mechanism. Crit Rev Oncog (1997) 1.23
Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy. Curr Cancer Drug Targets (2002) 1.20
Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene (2010) 1.18
Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem (2012) 1.14
Activating transcription factor 3 activates p53 by preventing E6-associated protein from binding to E6. J Biol Chem (2010) 1.12
Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. BMC Complement Altern Med (2012) 1.12
Food bioactives, apoptosis, and cancer. Mol Nutr Food Res (2008) 1.04
3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells. J Nutr Biochem (2012) 0.97
Mechanisms of naringenin-induced apoptotic cascade in cancer cells: involvement of estrogen receptor alpha and beta signalling. IUBMB Life (2004) 0.95
Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One (2014) 0.91
Naringenin-induced apoptosis via activation of NF-kappaB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett (2006) 0.89
The naringenin-induced proapoptotic effect in breast cancer cell lines holds out against a high bisphenol a background. IUBMB Life (2012) 0.88
Naringenin attenuates CCl4 -induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats. Clin Exp Pharmacol Physiol (2014) 0.85
Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res (2008) 0.85
Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells. Chem Biol Interact (2015) 0.84
Nutritional flavonoids modulate estrogen receptor alpha signaling. IUBMB Life (2004) 0.83
Negative regulation of beta-catenin/Tcf signaling by naringenin in AGS gastric cancer cell. Biochem Biophys Res Commun (2005) 0.81
Design, synthesis and inhibitory activities of naringenin derivatives on human colon cancer cells. Bioorg Med Chem Lett (2012) 0.80
ATF3 Mediates Anti-Cancer Activity of Trans-10, cis-12-Conjugated Linoleic Acid in Human Colon Cancer Cells. Biomol Ther (Seoul) (2015) 0.80
Anti-Proliferative Effect of Naringenin through p38-Dependent Downregulation of Cyclin D1 in Human Colorectal Cancer Cells. Biomol Ther (Seoul) (2015) 0.79
Modulatory effect of naringenin on N-methyl-N'-nitro-N-nitrosoguanidine- and saturated sodium chloride-induced gastric carcinogenesis in male Wistar rats. Clin Exp Pharmacol Physiol (2008) 0.78
A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer. Acta Gastroenterol Belg (2012) 0.76
Tanshinone I induces cyclin D1 proteasomal degradation in an ERK1/2 dependent way in human colorectal cancer cells. Fitoterapia (2015) 0.82
Silymarin induces cyclin D1 proteasomal degradation via its phosphorylation of threonine-286 in human colorectal cancer cells. Int Immunopharmacol (2014) 0.81
The contribution of activating transcription factor 3 to apoptosis of human colorectal cancer cells by protocatechualdehyde, a naturally occurring phenolic compound. Arch Biochem Biophys (2014) 0.76
The involvement of cyclin D1 degradation through GSK3β-mediated threonine-286 phosphorylation-dependent nuclear export in anti-cancer activity of mulberry root bark extracts. Phytomedicine (2015) 0.75